Literature DB >> 9577090

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

M C Mingari1, A Moretta, L Moretta.   

Abstract

Killer-cell inhibitory Receptors (KIRs) are a new family of major histocompatibility complex (MHC) class I-specific receptors. KIRs allow natural killer cells to identify and lyse self cells that do not express sufficient amounts of MHC class I molecules. Here, Maria Cristina Mingari and colleagues view the expression of KIRs by cytolytic T lymphocytes and their regulation by certain cytokines as a double-edged sword.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9577090     DOI： 10.1016/s0167-5699(97)01236-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  36 in total

Review 1.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  IFN-gamma suspends the killing license of anti-tumor CTLs.

Authors:  Aron E Lukacher
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.

Authors:  Chiara Romagnani; Gabriella Pietra; Michela Falco; Enrico Millo; Paola Mazzarino; Roberto Biassoni; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-07       Impact factor: 11.205

4.  Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption.

Authors:  Yoshiko Mizukawa; Yoshimi Yamazaki; Yuichi Teraki; Jun Hayakawa; Kazuhito Hayakawa; Hideko Nuriya; Michinori Kohara; Tetsuo Shiohara
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 5.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

6.  HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.

Authors:  Gabriella Pietra; Chiara Romagnani; Paola Mazzarino; Michela Falco; Enrico Millo; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 7.  Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.

Authors:  Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

8.  Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.

Authors:  Lola Jacquemont; Gaëlle Tilly; Michelle Yap; Tra-My Doan-Ngoc; Richard Danger; Pierrick Guérif; Florent Delbos; Bernard Martinet; Magali Giral; Yohann Foucher; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 10.121

9.  DSHP: a "power bar" for sustained immune responses?

Authors:  A B Satterthwaite; D J Rawlings; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.

Authors:  Andrew J Dunbar; Lukasz P Gondek; Christine L O'Keefe; Hideki Makishima; Manjot S Rataul; Hadrian Szpurka; Mikkael A Sekeres; Xiao Fei Wang; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.